Military deployment and retention rates in a subgroup of active duty military servicemembers after atrial fibrillation diagnosis comparing anticoagulation prescriptions
| All (n=365) | Deployed (n=147) | Non-deployed (n=218) | Retained (n=248) | Discharged (n=117) | |
| No anticoagulation | 194 (53%) | 75 (51%) | 119 (55%) | 125 (50%) | 69 (59%) |
| Any anticoagulation | 171 (47%) | 72 (49%) | 99 (45%) | 123 (50%) | 48 (41%) |
| Warfarin | 119 (70%) | 58 (81%) | 61 (62%) | 89 (72%) | 30 (63%) |
| DOAC | 52 (30%) | 14 (19%) | 38 (38%) | 34 (28%) | 18 (38%) |
| Dabigatran | 8 (15%) | 3 (21%) | 5 (13%) | 4 (12%) | 4 (22%) |
| Apixaban | 25 (48%) | 6 (43%) | 19 (50%) | 18 (53%) | 7 (39%) |
| Rivaroxaban | 19 (37%) | 5 (36%) | 14 (37%) | 12 (35%) | 7 (39%) |
Values are number, (%).
DOAC, direct oral anticoagulant.